| Line Item | Jun 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-controlled, non-affiliated investments: | |||||||||||||||
| Cash | — | — | — | ||||||||||||
| Payment in-kind | — | ||||||||||||||
| Total interest income | |||||||||||||||
| Dividend income | |||||||||||||||
| Total dividend income | |||||||||||||||
| Interest from cash and cash equivalents | |||||||||||||||
| Fee income (see Note 9) | |||||||||||||||
| Total Investment Income | |||||||||||||||
| Expenses: | |||||||||||||||
| Interest and financing expenses | |||||||||||||||
| Salaries and benefits | |||||||||||||||
| Professional fees, net | |||||||||||||||
| General and administrative expenses | |||||||||||||||
| Directors fees | |||||||||||||||
| Administrator expenses (see Note 6) | |||||||||||||||
| Insurance expenses | |||||||||||||||
| Total expenses | |||||||||||||||
| Net Investment Income | |||||||||||||||
| Net realized gains (losses): | |||||||||||||||
| Total net realized gains (losses) | |||||||||||||||
| Net change in unrealized gains (losses): | |||||||||||||||
| Total net change in unrealized gains (losses) | |||||||||||||||
| Deferred tax benefit (expense) | |||||||||||||||
| Loss on Extinguishment of Debt (see Note 5) | — | — | |||||||||||||
| Total realized and unrealized gains (losses) | |||||||||||||||
| Net Increase (Decrease) in Net Assets Resulting from Operations | |||||||||||||||
| Weighted average basic earnings per common share (in Dollars per share) | |||||||||||||||
| Weighted average diluted earnings per common share (in Dollars per share) |